Rocio Evangelista
Head, Preclinical Pharmacology Medical & Health Molecular Partners
Rocio Evangelista is a veterinarian by training and an expert in preclinical oncology research, currently serving as Head of Preclinical Pharmacology. With a career spanning major industry leaders like Roche, she specializes in driving preclinical candidate validation across two key pillars: Immuno-Oncology (IO) and Radioligand Therapy (RLT). Her work focuses on bridging innovative drug design with robust in vivo profiling to accelerate next-generation cancer therapies into the clinic.
Seminars
Wednesday 2nd December 2026
Evidence – Advancing the 3Rs Through Integrated Use of 3D Spheroids & In Vivo Models in Immuno-Oncology Development
1:00 pm
- Evaluating how 3D spheroids and advanced in vitro systems can complement in vivo studies to improve biological relevance and reduce animal use
- Determining which questions require complex in vivo models versus alternative approaches across different stages of development
- Building robust preclinical evidence packages that balance translational confidence, operational feasibility, and 3Rs principles
Wednesday 2nd December 2026
Insights Exchange – How Should Teams Select the Right Model Under Real World Constraints?
2:10 pm
- What characteristics consistently appear in models that successfully predict patient outcomes?
- Where do models most commonly fail despite encouraging preclinical data?
- Which translational endpoints should teams prioritise when evaluating model performance
- Audience Q&A
